Accessibility Menu
Biote logo

Biote

(NASDAQ) BTMD

Current Price$1.49
Market Cap$46.47M
Since IPO (2021)-86%
5 YearN/A
1 Year-66%
1 Month-30%

Biote Financials at a Glance

Market Cap

$46.47M

Revenue (TTM)

$192.22M

Net Income (TTM)

$27.05M

EPS (TTM)

$0.76

P/E Ratio

1.90

Dividend

$0.00

Beta (Volatility)

0.44 (Low)

Price

$1.49

Volume

2,734

Open

$1.45

Previous Close

$1.44

Daily Range

$1.45 - $1.53

52-Week Range

$1.35 - $4.75

BTMD News

No articles available.

BTMD: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Biote

Industry

Pharmaceuticals

Employees

223

CEO

Bret Christensen, MBA

Headquarters

Irving, TX 75038, US

BTMD Financials

Key Financial Metrics (TTM)

Gross Margin

71%

Operating Margin

18%

Net Income Margin

14%

Return on Equity

0%

Return on Capital

57%

Return on Assets

25%

Earnings Yield

52.63%

Dividend Yield

0.00%

Payout Ratio

6.39%

Stock Overview

Market Cap

$46.47M

Shares Outstanding

32.27M

Volume

2.73K

Short Interest

0.00%

Avg. Volume

187.36K

Financials (TTM)

Gross Profit

$137.36M

Operating Income

$35.55M

EBITDA

$39.22M

Operating Cash Flow

$35.19M

Capital Expenditure

$5.01M

Free Cash Flow

$30.18M

Cash & ST Invst.

$24.12M

Total Debt

$109.92M

Biote Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$46.41M

-6.9%

Gross Profit

$31.57M

-11.1%

Gross Margin

68.03%

N/A

Market Cap

$46.47M

N/A

Market Cap/Employee

$214.13K

N/A

Employees

217

N/A

Net Income

$1.95M

-47.2%

EBITDA

$3.97M

-226.4%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$85.80M

-20.0%

Accounts Receivable

$6.87M

-10.8%

Inventory

$19.06M

+28.4%

Long Term Debt

$103.08M

-1.0%

Short Term Debt

$6.84M

+1.0%

Return on Assets

25.13%

N/A

Return on Invested Capital

56.77%

N/A

Free Cash Flow

$6.49M

-42.5%

Operating Cash Flow

$7.57M

-38.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ACTUActuate Therapeutics Inc
$2.41-3.60%
SCLXScilex Holding Company
$7.73-0.90%
MCRBSeres Therapeutics, Inc.
$8.88-2.20%
INOInovio Pharmaceuticals, Inc.
$1.60-2.73%

Trending Stocks

Symbol / CompanyPricePrice Chg
ANNAAleAnna
$7.07+0.87%
TQQQProShares Trust - ProShares UltraPro Qqq
$44.34-0.03%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.56+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.69-0.02%

Questions About BTMD

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.